Industries
Life Sciences
Life sciences breakthroughs happen with Cooley
Practices
-
Band 1for US (Nationwide), California, Massachusetts and UK Life Sciences – Chambers, 2023#1for healthcare and life sciences IPOs since 2016 – Deal Point Data, 2024#1VC firm for pharma and biotech deals – PitchBook, 2023Top 2law firm for US life sciences M&A and venture capital – Mergermarket and PitchBook, 202340+dedicated, international professionals across the US, Europe and Asia exclusively focused on corporate partnering, licensing, M&A and other commercial transactions specific to life sciences companiesTier 1for Corporate, Licensing & Collaboration, Venture Capital, Mergers & Acquisitions, Patent Strategy & Management, and Patent Prosecution – LMG Life Sciences Americas, 2023 Life Sciences Practice Group of the Year – Law360, 2023Read more
-
100+venues argued before – including state, federal and international courts, arbitral forums, and administrative bodiesFivefellows of the American College of Trial Lawyers and 20+ former assistant US attorneys and Department of Justice lawyers within our teamDecadesof experience resolving high-stakes disputes in the pharmaceutical, biotechnology and medical device spaces across key jurisdictionsExperience in internal investigations and all aspects of white-collar and securities defense, including complex government investigations and enforcement actions for life sciences and healthcare companiesDefended more life sciences companies in shareholder litigation filed over the past 10 years than any other firmHistory of achieving groundbreaking victories on behalf of life sciences clients in the US Supreme Court and California Supreme Court, as well as complete wins in commercially significant drug ownership and licensing disputesRegularly defend False Claims Act actions arising from allegations of billing/coding misconduct, patient safety and research misconduct, manufacturing deficiencies, other Federal Food, Drug, and Cosmetic Act violations, drug pricing misconduct, federal and state anti-kickback law violations, and other relevant fraud and abuse laws led by local, state, and federal civil and criminal government enforcersRead more
-
Provide regulatory counseling and advice on US Food and Drug Administration (FDA), fraud and abuse, corporate compliance, contractual relationships, sunshine laws, reimbursement, government program price reporting, healthcare data privacy, licensure and accreditation, health reform counseling, regulatory due diligences, Medicines and Healthcare products Regulatory Agency (MHRA) and CE markingMultidisciplinary team of top lawyers advises all players in the evolving ecosystem, including payors, providers, life sciences companies, healthtech companies and investors, providing counseling on privacy and data protection, government contracts, and government analyticsHistory of leveraging our experience as connectors to the ecosystem to counsel clients on launching innovative products and servicesRepresent healthcare clients in connection with federal and state government investigations, inquiries, settlements and voluntary disclosures, leveraging subject matter knowledge and litigation and negotiation experienceFrequently contribute to groundbreaking regulatory topics at leading industry events, via editorial boards, and in relevant media and publicationsProvide comprehensive and timely guidance through CooleyREG, our innovative approach that brings together regulatory practitioners from across the firm to help clients navigate every regulatory twist and turnRead more
-
100+life sciences patent team members across the US and UK1,000+IP due diligence reviews in life sciences deals/transactions46,000+patents currently under our management worldwide and one of the more active IP litigation practices in the US, with 500+ cases in the last five yearsRecord of securing complete wins in commercially significant drug ownership and licensing disputesDecadesof experience litigating Hatch-Waxman matters for branded pharmaceutical companiesProvide guidance on selecting, clearing, protecting and obtaining regulatory approval for drug and device names with insight from our branding teamRead more
Band 1
for US (Nationwide), California, Massachusetts and UK Life Sciences – Chambers, 2023
#1
for healthcare and life sciences IPOs since 2016 – Deal Point Data, 2024
#1
VC firm for pharma and biotech deals – PitchBook, 2023
Top 2
law firm for US life sciences M&A and venture capital – Mergermarket and PitchBook, 2023
40+
dedicated, international professionals across the US, Europe and Asia exclusively focused on corporate partnering, licensing, M&A and other commercial transactions specific to life sciences companies
Tier 1
for Corporate, Licensing & Collaboration, Venture Capital, Mergers & Acquisitions, Patent Strategy & Management, and Patent Prosecution – LMG Life Sciences Americas, 2023 Life Sciences Practice Group of the Year – Law360, 2023
100+
venues argued before – including state, federal and international courts, arbitral forums, and administrative bodies
Five
fellows of the American College of Trial Lawyers and 20+ former assistant US attorneys and Department of Justice lawyers within our team
Decades
of experience resolving high-stakes disputes in the pharmaceutical, biotechnology and medical device spaces across key jurisdictions
Experience in internal investigations and all aspects of white-collar and securities defense, including complex government investigations and enforcement actions for life sciences and healthcare companies
Defended more life sciences companies in shareholder litigation filed over the past 10 years than any other firm
History of achieving groundbreaking victories on behalf of life sciences clients in the US Supreme Court and California Supreme Court, as well as complete wins in commercially significant drug ownership and licensing disputes
Regularly defend False Claims Act actions arising from allegations of billing/coding misconduct, patient safety and research misconduct, manufacturing deficiencies, other Federal Food, Drug, and Cosmetic Act violations, drug pricing misconduct, federal and state anti-kickback law violations, and other relevant fraud and abuse laws led by local, state, and federal civil and criminal government enforcers
Provide regulatory counseling and advice on US Food and Drug Administration (FDA), fraud and abuse, corporate compliance, contractual relationships, sunshine laws, reimbursement, government program price reporting, healthcare data privacy, licensure and accreditation, health reform counseling, regulatory due diligences, Medicines and Healthcare products Regulatory Agency (MHRA) and CE marking
Multidisciplinary team of top lawyers advises all players in the evolving ecosystem, including payors, providers, life sciences companies, healthtech companies and investors, providing counseling on privacy and data protection, government contracts, and government analytics
History of leveraging our experience as connectors to the ecosystem to counsel clients on launching innovative products and services
Represent healthcare clients in connection with federal and state government investigations, inquiries, settlements and voluntary disclosures, leveraging subject matter knowledge and litigation and negotiation experience
Frequently contribute to groundbreaking regulatory topics at leading industry events, via editorial boards, and in relevant media and publications
Provide comprehensive and timely guidance through CooleyREG, our innovative approach that brings together regulatory practitioners from across the firm to help clients navigate every regulatory twist and turn
100+
life sciences patent team members across the US and UK
1,000+
IP due diligence reviews in life sciences deals/transactions
46,000+
patents currently under our management worldwide and one of the more active IP litigation practices in the US, with 500+ cases in the last five years
Record of securing complete wins in commercially significant drug ownership and licensing disputes
Decades
of experience litigating Hatch-Waxman matters for branded pharmaceutical companies
Provide guidance on selecting, clearing, protecting and obtaining regulatory approval for drug and device names with insight from our branding team
According to industry peers, the licensing, tax and inversion, private investment, capital market and M&A work performed by Cooley is top tier.
LMG Life Sciences
Life Sciences & Healthcare Innovation Hub
A comprehensive resource for key stakeholders across the global life sciences and healthcare industry
It is an excellent firm. They know the space and know the ins and outs of the technology we are developing and commercializing.
Chambers
Group contacts
Betsy Flanagan
Partner
Betsy Flanagan
Partner
Betsy Flanagan
Partner